Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Current Leases (2020 - 2025)

PROCEPT BioRobotics has reported Current Leases over the past 6 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Current Leases at $2.2 million for Q4 2025, up 15.92% from a year ago — trailing twelve months through Dec 2025 was $2.2 million (up 15.92% YoY), and the annual figure for FY2025 was $2.2 million, up 15.92%.
  • Current Leases for Q4 2025 was $2.2 million at PROCEPT BioRobotics, up from $2.1 million in the prior quarter.
  • Over the last five years, Current Leases for PRCT hit a ceiling of $3.0 million in Q1 2023 and a floor of $1.7 million in Q4 2023.
  • Median Current Leases over the past 5 years was $2.1 million (2021), compared with a mean of $2.1 million.
  • Biggest five-year swings in Current Leases: skyrocketed 37.46% in 2023 and later plummeted 43.26% in 2024.
  • PROCEPT BioRobotics' Current Leases stood at $2.1 million in 2021, then increased by 1.14% to $2.1 million in 2022, then fell by 20.95% to $1.7 million in 2023, then rose by 13.49% to $1.9 million in 2024, then increased by 15.92% to $2.2 million in 2025.
  • The last three reported values for Current Leases were $2.2 million (Q4 2025), $2.1 million (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.